- Gliflozines: inhibitors of SGLT 22013 | Second Faculty of Medicine
- Gliflozins in the treatment of type 1 diabetes mellitus2020 | Faculty of Medicine in Hradec Králové
- Inhibition of SGLT-2 as a new approach in the treatment of type 2 diabetes mellitus2013 | First Faculty of Medicine, Third Faculty of Medicine
- Dapagliflozin2013 | Faculty of Medicine in Hradec Králové
- Efficacy and safety of ertugliflozin in type 2 diabetes monotherapy in the extension of the VERTIS MONO study. Comment2020 | Faculty of Medicine in Hradec Králové
- Diabetes mellitus and gynecological infections2015 | First Faculty of Medicine
- How will diabetes treatment change with new pharmaceuticals?2015 | Second Faculty of Medicine
- Pacient s onemocněním ledvin v ordinaci diabetologa2017 | First Faculty of Medicine
- Nové možnosti farmakoterapie srdečního selhání u pacientů s chronickým onemocněním ledvin2019 | First Faculty of Medicine
- New treatment options for chronic kidney disease - focused on SGLT2 inhibitors2021 | First Faculty of Medicine
- Fournier's gangrene and gliflozins in therapy of diabetes mellitus2019 | Third Faculty of Medicine, Second Faculty of Medicine
- Co přinesl rok 2022 v diabetologii2023 | First Faculty of Medicine
- Canagliflozin: trochu jiný SGLT2 inhibitor2019 | Second Faculty of Medicine
- New possibilities in treatment of type 2 diabetes2012 | Second Faculty of Medicine
- Dapagliflozin - a new option in treating type 2 diabetes mellitus2015 | Second Faculty of Medicine
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study2018 | First Faculty of Medicine